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Abstract
We initially studied requirements for 5′ and 3′ terminal regions (TRs) in flavivirus negative strand synthesis in vitro. Purified West Nile (WNV)
and dengue-2 (DV2) RNA polymerases were both active with all-WNVor all-DV2 subgenomic RNAs containing the 5′- and 3′TRs of the respective
genomes. However, subgenomic RNAs in which the 5′-noncoding region (5′NCR) or the 5′ORF (nts 100–230) in the 5′TR were substituted by
analogous sequences derived from the heterologous genome were modestly to severely defective as templates for either polymerase. We also
evaluated the infectivity of substitution mutant WNV genome-length RNAs. All WNV RNAs containing the DV2 3′SL were unable to replicate.
However, WNV RNAs containing substitutions of the 5′NCR, the capsid gene, and/or 3′NCR nt sequences upstream from the WNV 3′SL, by the
analogous DV2 nt sequences, were infectious. Combined results suggested that replication was not dependent upon species homology between the 3′
SL and NS5.
© 2007 Elsevier Inc. All rights reserved.Keywords: Flavivirus RNA replication; RNA cyclization; Flavivirus polymerase activityIntroduction
Dengue and West Nile viruses (WNV) are members of dif-
ferent groups among mosquito-borne flaviviruses, based on
serologic and genetic relatedness (Calisher et al., 1989). The
flavivirus genome is about 10.5 kb in total length and contains a
single long open reading frame (ORF), encoding three viral
structural proteins and at least seven nonstructural (NS) proteins.
The ORF is flanked by a 5′-noncoding region (NCR) which is
about 96 to 100 nucleotides (nt) in length and by a 3′NCRwhich
is 400 to 800 nt in length depending on the flavivirus (reviewed
in Lindenbach and Rice, 2003). The dengue 3′NCR is among the
shortest within the genus, at ∼450 nts, while the 3′NCRs of the
JE group, including WNV, are ∼630 nts in length. Conse-
quently, the WNV 3′NCR contains nt sequences, including but
not limited to tandem repeat sequences, CS3 and RCS3, not⁎ Corresponding author. CBER/FDA, BLDG. 29A, RM 1B18, 8800 Rockville
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doi:10.1016/j.virol.2007.12.035present in the DV 3′NCRs (reviewed in Markoff, 2003). The 5′-
and 3′-terminal 100 nts of the flavivirus genome each form
thermodynamically stable stem–loop structures, here referred to
as the 5′SL and 3′SL, respectively (Brinton and Dispoto, 1988;
Brinton et al., 1986; Grange et al., 1985; Gritsun et al., 1997;
Khromykh et al., 2003; Mohan and Padmanabhan, 1991;
Proutski et al., 1997; Shi et al., 1996;Wengler and Castle, 1986).
The 3′SL secondary structure is essential for minus strand
RNA synthesis and for virus replication in infected mammalian
cells (Khromykh et al., 2003; Tilgner and Shi, 2004; You et al.,
2001; Yu and Markoff, 2005; Zeng et al., 1998). Within the 3′
SL, the long stem segment contains bulges due to mismatching
of base pairs in the adjacent strands. The loci of these bulges are
not well conserved among flavivirus species. Nonetheless,
integrity of specific bulges is required for RNA replication
(Tilgner et al., 2005; Yu and Markoff, 2005). This was thought
to account for the previous observation that the respective 3′SL
nt sequences could not be swapped between the WNV and
dengue-2 strain New Guinea C (DV2) genomes. The 3′SL also
binds host cellular proteins in vitro (Blackwell and Brinton,
1995; Blackwell and Brinton, 1997; De Nova-Ocampo et al.,
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nonstructural proteins NS3 and NS5 bind the 3′SL in context
with the 3′NCR (Chen et al., 1997). The amino-terminus of NS3
contains a serine protease activity; its carboxy-terminus con-
tains NTPase, RNA helicase, and 5′-RNA triphosphatase
activities all thought to be required for RNA replication (for
reviews, see Lindenbach, 2007). NS5 contains the RNA-
dependent RNA polymerase activity (Ackermann and Padma-
nabhan, 2001; Tan et al., 1996), as well as 2′ O- and N-
methyltransferase activities needed for capping nascent viral
RNAs (Egloff et al., 2002; Ray et al., 2006). Most if not all the
NS proteins are part of the replication complex (Khromykh et
al., 2000).
The 5′NCR is required both for RNA synthesis (Ackermann
and Padmanabhan, 2001; Cahour et al., 1995; Filomatori et al.,
2006; Nomaguchi et al., 2004; You et al., 2001) and for viral
RNA translation (Chiu et al., 2005; Holden and Harris, 2004). A
recent observation that may account for the requirement for the
5′NCR in RNA synthesis was the demonstration that a specific
tri-nucleotide sequence within the conserved stem–loop “A” in
the 5′SL is recognized by NS5 as a precondition for initiation of
negative strand RNA synthesis (Filomatori et al., 2006).
Accumulated evidence suggests that the flavivirus RNA
forms a panhandle structure for initiation of negative strand
RNA synthesis. RNA elements required for 5′/3′ terminal region
(TR; here defined as the 5′NCR, 5′ORF, and 3′NCR nt se-
quences) hydrogen bonding include the 5′CS, an 8-nt sequence
within the ORF (nts 137–144 in the WNV genome) that is
conserved among mosquito-borne flaviviruses and CS1, a 23- to
25-nt 3′TR element that lies just upstream from the 3′SL in the 3′
NCR and contains an 8-nt cyclization sequence (cyc) comple-
mentary to the 5′CS (Hahn et al., 1987). Complementarity
between the cyc sequence and the 5′CS is required for negative
strand RNA synthesis. There is additional complementarity
between the 5′ and 3′TRs, including but not limited to the 5′ and
3′ “UAR” nt sequences that lie upstream from the start codon
and upstream from the 3′SL, respectively (Ackermann and
Padmanabhan, 2001; Alvarez et al., 2005a,b; Bredenbeek et al.,
2003; Corver et al., 2003; Filomatori et al., 2006; Khromykh
et al., 2001; Lo et al., 2003; Nomaguchi et al., 2004; You et al.,
2001; Yu and Markoff, 2005; Zeng et al., 1998). Despite the
accumulated information, there are still large gaps in our under-
standing of the specific nature of the interaction of 5′ and 3′
secondary structures with virus and host proteins to form the
replication complex.
To gain additional relevant data, we first examined the ability
of RNA synthesis templated by the WNV 3′NCR to be tran-
sactivated by added 5′TR nt sequences derived from the WNV
and/or the DV2 genome in vitro, using purified WNV NS5 as
catalyst. We created a series of WNV and DV2 “minigenome”
RNAs containing 5′NCR, 5′ORF and 3′NCR nt sequences in
covalent linkage. Homologous (all-WNV or all-DV2) and
WNV/DV2 chimeric minigenome RNAs were assayed for
their ability to serve as template for minus strand RNA synthesis,
using purified DV2 and WNV NS5 viral polymerase proteins
(Ackermann and Padmanabhan, 2001; Nomaguchi et al., 2004).
We also engineeredWNV infectious RNAs that contained DV2-for-WNV nt substitution mutations of the 5′NCR, 5′ORF, and
the 3′NCR or functional elements thereof. These RNAs were
analyzed for their replication competence in vivo. The combined
data suggested that the requirement for the homologous 3′SL for
viral replication is related to specificities of viral NS proteins
other than NS5 or to an effect on NS5 specificity conferred by its
interaction with other NS proteins or cellular proteins required to
form the replication complex. Additional information regarding
specific requirements for 5′ and 3′TR nt sequence elements in
flavivirus RNA replication and parallels between the in vitro and
in vivo results were also gained from this work.
Results
5′TR nt sequences required for in vitro RNA synthesis catalyzed
by purified NS5 proteins
We previously demonstrated that negative strand RNA syn-
thesis templated by the WNV 3′NCR and catalyzed by purified
WNV NS5 was dependent upon the presence of WNV 5′ ter-
minal nt sequences that included both the 5′NCR and the 5′CS in
covalent linkage to the 3′NCR (Nomaguchi et al., 2004). Prior to
initiating the present work, we established that RNA synthesis
catalyzed by purified WNV NS5 protein could also be activated
in trans by WNV 5′ terminal region (TR) nt sequences (data not
shown), provided that the WNV 5′CS, as well as the 5′NCR,
was included in the transactivating RNA, as had been demon-
strated for the DV2 NS5 using analogous DV2 5′TR RNAs
(Ackermann and Padmanabhan, 2001; You et al., 2001; You and
Padmanabhan, 1999). We then sought to determine whether
heterologous or chimeric 5′TR230nt RNAs (i.e., the 5′NCR plus
the first 130 nts of the capsid gene ORF) could transactivate in
vitro RNA synthesis catalyzed by the WNV NS5, using the
WNV 3′NCR631nt RNA as template. Four 5′TR230nt RNAs were
generated for this assay. Two control RNAs contained,
respectively, the 5′ 230 nts of the DV2 and WNV genomes. A
third RNA contained the DV2 5′NCR (DV2 nts 1–99) cova-
lently linked to the 5′ terminus of the WNV ORF (nts 100–230)
(DV 5′NCR-WNV 5′ORF RNA), and the fourth contained the
WNV 5′NCR (nts 1–99) covalently linked to DV2 nts 100–230
(WNV 5′NCR-DV5′ORF RNA). The 8-nt 5′CS sequence
(WNV nts 137–144 or DV2 nts 134–141) per se is conserved
between these two genomes (Khromykh et al., 2001). Therefore,
any differences between the heterologous or chimeric 5′TRs in
trans-activation of RNA synthesis from the WNV 3′NCR,
compared to that of the wt WNV 5′TR, were expected to be due
to nt sequence heterogeneity within the 5′NCR or within the
ORF (nts 100–230), up or downstream from the 5′CS. An effect
of these sequences in the corresponding region of the yellow
fever genome on RNA replication was previously reported
(Corver et al., 2003).
Trans-activation of RNA synthesis was scored by observa-
tion of the relative amounts of both 3′ elongation and de novo
products. Previous studies demonstrated that the “3′ elongation
products” represent negative sense extension initiated at the 3′
terminus of the 3′NCR which generates a hairpin product
molecule that is about twice the length of input templates,
Table 1
Relative polymerase activity of WNV and DV2 NS5 proteins with indicated
templates
NS5 Product a Yield from indicated template b
WN818nt D2719nt A
c B C WN1051nt
WNd De novo 1.0 0.96 0.41 0.58 0.37 1.9
3′ elongation 1.0 1.22 0.31 0.25 0.12 1.06
D2 De novo 0.36 1.0 0.35 0.94 0.37 NTe
3′ elongation 0.72 1.0 0.12 0.49 0.06 NT
a “De novo”RNAmolecules represent full-length negative strand RNA copies
of the respective RNA templates. “3′ elongation” products represent input RNA
covalently linked at the 3′ terminus to approximately full-length negative
stranded copies of the template.
b Pixel densities of representative bands on the gel shown as Figs. 1C and D
were determined using the program ImageQuant. Results for the WNV NS5
polymerase were normalized to those obtained with theWN818nt RNA (shown in
bold). Results for the DV2 NS5 polymerase were normalized to those obtained
with the D2719nt RNA (shown in bold).
c A, WN1–161D23′NCR RNA template; B, WN1–95D296–230+ 3′NCR RNA
template; C, D21–208WN3′NCR RNA template.
d WN, West Nile; D2, Dengue-2. NS5 proteins were expressed in E. coli and
purified as described in Materials and Methods. Reactions were conducted as
described elsewhere.
e NT, not tested.
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RNAs (Ackermann and Padmanabhan, 2001; Nomaguchi et al.,
2004; You et al., 2001). Transactivation was optimal in the
presence of the homologous WNV 5′TR230nt RNA (Fig. 1A,
lane 8). In contrast, RNA synthesis was barely detectable, when
the DV2 5′TR230nt RNA was present in this assay (Fig. 1A,
lane 2). Both chimeric 5′TR230nt RNAs exhibited some activity
for trans-activating RNA synthesis from the WNV 3′NCR631nt
(Fig. 1A, lanes 4 and 6) but less than the WNV 5′TR230nt
control. In this regard the DV5′NCR-WNV5′ORF RNA was
slightly superior to the WNV5′NCR-DV5′ORF RNA. Thus the
in vitro system was sensitive to nt sequence differences between
the 5′ 230 nts of theWNV genome and those of the DV2 genome
for the interaction of exogenous RdRp and the 5′ and 3′TRs in
mediating RNA synthesis from the WNV 3′NCR, not-
withstanding the conservation of the 5′CS and cyc nt sequences.
Possibly, the slight superiority of the DV5′NCR-WNV5′ORF
RNA, compared to the WNV5′NCR-DV5′ORF RNA as a
trans-activator of RNA synthesis, was an indicator that dif-
ferences in nt sequence between the two ORFs were a deter-
minant of the results. The assay shown in Fig. 1Awas repeated at
least three times and gave similar results each time. Also, visual
observations used as a basis for evaluating the relative templateactivities of these constructs were confirmed by direct
quantification of radiolabel in RNA localized to the bands
labeled as 3′ elongation and de novo products, respectively, in
Fig. 1A (data not shown).
We then assayed the relative ability of purified DV2 or WNV
NS5 polymerases to catalyze RNA synthesis from each of six
“minigenome” RNAs that contained homologous, heterologous,
or chimeric 5′- and 3′-TRs covalently linked in template RNAFig. 1. Nt sequence requirements for in vitro RdRP activity using purified WNV
and DV2 NS5. In vitro RdRP assays were performed as previously described
(Nomaguchi et al., 2004; You and Padmanabhan, 1999). Radiolabeled RNA
product molecules of in vitro RdRp reactions were separated by gel
electrophoresis and visualized by autoradiography also as previously described
(Ackermann and Padmanabhan, 2001). (A) Transactivation of RNA synthesis
of the WN3′NCR631nt RNA using heterologous or chimeric 5′TRs. RdRP
reactions were carried out in the presence (+) or absence (−) of WN3′NCR631nt
RNA. Lanes 1 and 2: reactions contained an RNA bearing the 5′ terminal 230 nts
of the Dengue-2 strain NGC genome (DV5′TR230nt). Lanes 3 and 4: reactions
contained a chimeric RNA representing the 5′NCR (nts 1–95) of the WNV
genome covalently linked to nts 96–230 of the 5′ terminus of the DV ORF
(WN5′NCR-DV5′ORF). Lanes 5 and 6: reactions contained a chimeric RNA
representing the DV 5′NCR nts 1–95 linked to the WN nts 96–230 (DV5′NCR-
WN5′ORF). Lanes 7 and 8: reactions contained WN5′TR230nt RNA. Lane 9:
reaction contained onlyWN3′NCR631nt RNA, as control. (B and C) In vitro RdRP
assays catalyzed by the WNV NS5 (B) or the DV2 NS5 (C) were done using
homologous, heterologous, and chimeric WNV/DV2 minigenome RNAs as
templates.WNV1051nt RNA contained the 5′ terminal 281 nts of theWNV genome
fused to the 3′ terminal 770 nts, consisting of the 3′ terminal 139 nts of the WN
ORF plus the entire 631-nt 3′NCR.WNV818nt RNA containedWNV 5′ nts 1–161
fused to the 3′ terminal 656 nts of the WNV genome, consisting of the 3′ terminal
25 nts of the ORF plus the 631-nt 3′NCR.DV2719nt RNA contained the 5′ terminal
227 nts of the DENV2 genome fused to the 3′ terminal 41 nts of the ORF plus the
entire 451-nt 3′NCR. The construction of chimeric RNAs and conditions for PCR
followed by in vitro transcription are described under Materials and methods. The
conditions for standard RdRP assays were previously described (Nomaguchi et al.,
2004; You and Padmanabhan, 1999). The locations in the gel of 3′ elongation
products are indicated by solid arrows. The locations of de novo RNA products are
indicated by open arrows.
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and the WN818nt minigenomes for synthesis of the characteristic
product molecules with similar efficiency (Fig. 1B, lanes 1 and 6;
Table 1). The DV2 polymerase showed a distinct preference for
the homologous wt D2719nt minigenome but did recognize the
WN818nt template, with yields of de novo product less than 3-fold
reduced compared to those seenwithD2719nt RNA (Fig. 1C, lanes
1 and 5; Table 1). For the WNV polymerase, all of the chimeric
minigenomes were consistently less efficient templates for RNA
synthesis than were the two wt ones (Table 1). The D21–
208WN3′NCR and WN1–161D23′NCR minigenomes, in that order,
were the least efficient templates, regardless of the source of the
polymerase (Figs. 1B, C; Table 1). The result for D21–208WN3′NCR
RNA was congruent with that seen in the previous experiment,
where 5′TRs were presented in trans (Fig. 1A). The construct
composed of theWNV5′NCR (nts 1–95) fused to theDV2 5′ORF
(nts 96–230, where the start codon is located at nts 97–99) and the
DV2 3′NCR exhibited a vigorous template activity, when the
reaction was catalyzed by DV2 NS5 and was less efficient as
a template for the WNV NS5 (Fig. 1B, lane 4; Fig. 1C, lane 3;
Table 1). This was also analogous to results of the transactiva-Fig. 2. Replication ofWNVviruses containing DV2 3′NCR substitutionmutations. Th
tested. The WNV ORF is represented as a stippled rectangle. WNV 5′ and 3′NCR n
sequences are represented by closed rectangles. Nts comprising the 3′SL are indicated
derived from the DV2 genome that were appended to theWNVgenome at the site in th
panel exhibits the results of IFA on the day indicated. Vero cells were transfected wi
WN/DV3′USL, as indicated on the left. At 5-day intervals up to 20 days post-transfecti
anti-WNVanti-serum, and stained with fluorescein isothiocyanate-conjugated goat-ation experiments, where the chimeric 5′TR composed of DV2 nts
1–99 and WNV ORF nts 100–230 was shown to be a relatively
efficient trans-activator of RNA synthesis templated by the WNV
3′NCR and catalyzed by the WNV polymerase (Fig. 1A) and
suggested the significant positive effect of species homology
between the 5′ORF and the 3′NCR. Assays shown in Figs. 1B and
Cwere repeated at least three times and gave qualitatively identical
results each time. Radiolabeled products of indeterminate size, seen
particularly in Fig. 1C, were interpreted to represent incomplete 3′
elongation or de novo productmolecules, respectively, according to
their apparent size.
Requirements for infectivity of wild type and 5′ and 3′TR
chimeric WNV RNAs
The results described above demonstrated some aspects of the
specific interaction between the 3′NCR and the 5′TR that are
required for optimal RNA synthesis in vitro, in a system that
lacks NS3 and other viral NS and possibly cellular proteins
thought to confer specificity (Khromykh et al., 2000). We next
sought to examine this issue further in vivo, starting from oure left panel shows schematic representations of the wt andmutantWNV genomes
t sequences are represented by open rectangles, and the DV2 5′ and 3′NCR nt
by vertically oriented rectangles. Nucleotide numbers in parenthesis indicate nts
eWNVgenome indicated by the nt number to the left of the parenthesis. The right
th RNAs of Wt WNV, WNV/DV3′SL, WNV/DV3′NCR, WNV/DV3′UCS, and
on, the cells transferred to a coverslip were fixedwith acetone, treated withmouse
nti-mouse immunoglobulin G.
Fig. 3. Replication of WNV genomes containing DV2 5′NCR substitution mutations. (A) Nucleotide sequence alignment of WNV and DV2 5′NCRs. Conserved
nucleotide segments are boxed. There is about 50% sequence identity. The translation start codon AUG is underlined. (B) WNV genomes bearing substitutions of the
5′NCR by that of the DV2 genome are depicted, and the results of an IFA to detect virus replication in transfected Vero cells are shown. The experimental details are
same as in Fig. 2.
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interchangeable between the DV2 and WNV genomes (Yu
and Markoff, 2005; Zeng et al., 1998). To achieve our goal,
several chimeric WNV/DV2 full-length RNAs were generated
in vitro and tested for replication competence by transfection of
Vero cells. We initially created three WNV chimeras with DV2
3′NCR substitutions. In the first, the entire WNV 3′NCR
including the 3′SL (WNV nt 10,389–10,962) was replaced by
the corresponding DV2 3′NCR segment (construct C). In the
second and third, only the segments of the WNV 3′NCR
upstream of CS1 (3′UCS1) and the 3′NCR upstream of the 3′SL
(3′USL), respectively, were substituted by the analogous DV2
segments (Fig. 2, constructs D and E, respectively). Replication
of viruses produced from transfected wt and mutant RNAs was
assayed by an immune fluorescence assay (IFA) specific for
expression of WNV antigens in transfected cells. “Viable”
viruses gave positive results by IFA within 20 days after
transfection, whereas RNAs used to transfect cell monolayers
that remained negative during this observation period were
considered to bear “lethal” mutations. Chimeric WNV RNA
transcripts derived from construct C and a negative control
construct containing the 3′SL of DV2 substituted for the WNV
3′SL nt sequence (construct B) produced no WNV-specific
antigens (Figs. 2B and C) or virus plaques (data not shown) in
Vero cells. In contrast, viruses derived from construct D
(Fig. 2D) and E RNAs (Fig. 2D) were similar to wt WNV in
kinetics of replication as assessed by IFA (Fig. 2A).
As shown also by results of an infectious center assay (ICA)
and a plaque assay (see below), infectious progeny viruses were
produced from cells transfected with construct D and E RNAs.
Furthermore, virion RNAs were isolated from infected cell su-pernatants and sequenced. Results confirmed the stability of the
mutations in input RNA in all cases (data not shown). A com-
parison of the phenotypes of RNA constructs C and E suggested
that the lethal phenotype of C was solely due to the substitution
of the DV2 3′SL for the WNV 3′SL. Thus DV2 3′NCR nt
sequences could functionally replace analogous segments of the
WNV genome, despite the divergence in nt sequence and total
length of the 3′NCR between the two genomes (reviewed in
Markoff, 2003), provided only that the WNV 3′SL was retained
within the WNV RNA. These phenotypes were reproducibly
observed.
WNV genomes bearing a substitution of the WNV 5′NCR by the
DV2 5′NCR
Alignment of the 5′NCR nt sequences in DV2 and WNV
RNAs revealed less than 50% identity (Fig. 3A). We therefore
sought to determine whether the WNV 5′NCRwas a determinant
of the specific requirement for the WNV 3′SL for replication of
WNV. To address this question, we created two additional chi-
meric WNV genome RNAs. In the first, the WNV 5′NCR was
substituted by the DV2 5′NCR (Fig. 3B;WN/DV5′TR99nt RNA),
and in the second, theDV2 5′NCRand theDV2 3′SL replaced the
corresponding WNV segments (Fig. 3B; WN/DV5′TR99nt3′SL
RNA). Once again, virus replication was first assessed by IFA on
transfected cells. WN/DV5′TR99nt RNA gave a positive result by
day 5 after transfection, similar to wt WNV RNA, and progeny
viruses were produced from transfected cells. Furthermore, nt
sequence analysis of RNA recovered from transfected cells
indicated that WN/DV5′TR99nt RNA was genetically stable. In
contrast, substitution of both the 5′NCR and the 3′SL of theWNV
175L. Yu et al. / Virology 374 (2008) 170–185genome with the corresponding regions of DV2 in WN/
DV5′TR99nt3′SL RNA resulted in a lethal phenotype with no
viral antigens detected up to 20 days post-transfection in
repeated experiments (Fig. 3B). Thus, the lethal effect of
substituting the WNV 3′SL nt sequence with that of the DV2
genome could not be abrogated by substitution of the WNV
5′NCR with the analogous DV2 nt sequence.
Next, to determine whether the heterologous DV2 capsid
nt sequences up or downstream from the 5′CS could affect
replication of chimeric WNV/DV2 RNAs, we constructed
three mutant WNV infectious DNAs, all of which contained
a 5′ terminal substitution of WNV nts 1 to 159 by the
analogous region from the DV2 genome (Fig. 4A). This
region includes the entire 5′NCR and the first 21 codons of the
capsid gene and therefore encompassed the 5′CS (WNV nts
137–144). This mutation was paired with the wtWNV 3′NCR
in WNV/DV5′TR159nt DNA, with the 3′NCR of DV2 in
WNV/DV5′TR159nt 3′NCR DNA, or with a chimeric 3′NCRFig. 4. Replication of WNV genomes containing heterologous or homologous DV2 5′
5′NCR and nts 100–159 of the 5′ORF, which includes the 5′ cyclization sequenc
DV5′TR159nt3′NCRRNA) or the DV2 3′NCR upstream from theWNV 3′SL (WN/DV
Vero cells, andWNvirus replicationwasmonitored by an IFA conducted at 5-day interva
coverslip. Negative results on day 20 post-transfection of the RNAs are indicated on the
constructed and are depicted on the left, except that in each case the entire ORF of the D
capsid. Results of the IFA (described in part A and in the legend to Fig. 2) on day 20 pconsisting of a substitution of DV2 nt sequences upstream
from theWNV 3′SL inWNV/DV5′TR159nt 3′SL DNA.When
RNAs synthesized from these mutant DNAs were transfected
into Vero cells, none of them showed any signal for
replication, as detected by IFA up to 20 days post-transfection
(Fig. 4A). No virus release was detected by plaque assays
(data not shown). Thus, all three clones exhibited lethal
phenotypes.
The lethal phenotype of WNV/DV5′TR159nt RNAwas most
likely due either to dysfunction of the chimeric capsid protein
encoded by the latter genome or to a requirement for nts within
the WNV ORF upstream or downstream from the 5′CS for 5′/3′
end interaction. To test these alternative hypotheses, we con-
structed three more mutantWNVinfectious cDNAs in which the
entire coding sequence of the WNV capsid was replaced by that
of the DV2 capsid (Fig. 4B). TheWNVmutant RNA containing
the DV2 5′NCR and the entire DV2 capsid gene segment
(WNV/DV5′TR387nt) was able to replicate but gave a positiveand 3′CS elements. (A)WNV/DV2 chimeric genome RNAs containing the DV2
e (CS), minus (WN/DV5′TR159nt RNA) or plus the entire DV2 3′NCR (WN/
5′TR159nt3′USL RNA) are depicted on the left. These RNAs were transfected into
ls up to day 20 post-transfection, on an aliquot of cells that had been transferred to a
right. (B)WNV/DV2 chimeric genomes analogous to those depicted in part Awere
V2 capsid gene segment (nts 100–387) was substituted for the ORF of the WNV
ost-transfection of the indicated RNAs are shown on the right.
Table 3
Results of infectious center assays for wild type and mutant RNAs in Vero cells





a Vero cells were transfected with the indicated viral RNAs. Then transfected
cells were serially diluted, plated on 6-well plates, and overlaid with agarose.
Plates were incubated for 5–8 days, then cells were fixed and stained to visualize
plaques. Average results of two separate experiments are shown.
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panel). The lag in viral replication as determined by IFA was
consistent with the results from other analyses based on the
kinetics of plaque formation and plaque morphology (see
below). Sequencing of progenyWNV/DV5′TR387nt virion RNA
revealed that the expectedDV2 sequences from nts 1 to 387were
retained. However, we detected three point mutations, two
within the prM gene segment and one within the NS5 gene
segment (Table 2). Whether these point mutations were due to
PCR-introduced errors or represent necessary compensatory
mutations was not directly examined. Thus, the chimeric struc-
ture of the capsid protein was at least partly a cause of the lethal
phenotype of WN/DV5′TR159nt RNA and the related mutant
RNAs derived from it (Fig. 4A), although replacement of the
entire WNV capsid gene segment in WN/DV5′TR159nt RNA
with that of DV2, in the context of WN/DV5′TR387nt RNA, did
not completely “repair” the defect. In contrast, an analogous
mutant RNA in which the entire WNV 3′NCR was replaced by
that of DV2 (WN/DV5′TR387nt 3′NCR RNA) and one in
which only the WNV 3′SL was replaced by that of DV2 (WN/
DV5′TR387nt 3′SL RNA) were completely unable to replicate
(Fig. 4B; bottom two panels). These results again demon-
strated the prime importance of the homologous 3′SL nt
sequence in WNV RNA replication, regardless of the origin of
the 5′TR or upstream 3′NCR nt sequences.
Specific infectivity of mutant WNV RNAs and growth kinetics
and plaque morphology of viable viruses
We estimated the specific infectivity of viable mutant WNV
RNAs by an infectious center assay for plaque formation on Vero
cell monolayers (Table 3). Results suggested that wt WNV, WN/
DV5′TR99nt and WN/DV3′USL RNAs were comparably infec-
tious, whereas WN/DV5′TR387nt RNAwas at least 100-fold less
infectious than any of the others. This could indicate that theWN/
DV5′TR387nt genome was relatively defective for RNA replica-
tion or alternatively that the structurally chimeric virus encoded
by WN/DV5′TR387nt RNA was defective either in virion
morphogenesis or in the capacity of chimeric particles to infect
adjacent cells in the monolayer. The finding that transfected cells
did not become positive for WNV antigens until late times after
transfection suggests that in fact the defect is at the level of RNA
synthesis since we would have expected WNV antigens to have
been detectable in transfected cells at early times post-transfec-
tion, if the defect was at the level of virion morphogenesis.
As another measure of virus replication competence, the
growth rates of wt and viable mutants in Vero and C6/36 cellsTable 2
Second site mutations in WN/DV5′TR387nt RNA
Nucleotide no. a AA no. b Mutation AA change Gene segment
522 142 C to U Silent prM
611 172 U to C LLe to Thr prM
8763 2889 C to A Silent NS5
a Based on nt sequence of WNV strain 956 genome (GenBank M12994).
b Amino acid (AA) number referenced to the start codon for the single long
ORF in the WNV genome.were determined at a multiplicity of infection of 0.01 in each
case, using plaque-titered stocks. After infection, plaque
assays were done daily for the virions secreted into the
medium for 8 days. The peak titer for wt WNV in Vero cells
was about 1.5×108 pfu/ml, achieved at day 4 post-infection
(Fig. 5A), whereas the titer of WNV/DV5′TR99nt virus was
about 10-fold lower than wt at day 4. However, by day 6 this
virus reached a peak titer of 3.5×107 pfu/ml. Similarly, the
titer of WNV/DV3′USL virus was almost 100-fold lower than
that of wt WNV at day 4 after infection, but it ultimately
reached a peak titer of about 2.5×107 pfu/ml (Fig. 5A). In
contrast, WNV/DV5′TR387nt virus reached a titer comparable
to that of WNV/DV3′USL virus at day 4, but the peak titer
never exceeded 1×106 pfu/ml in Vero cells. Thus if the
spontaneous mutations detected in the WNV/DV5TR387nt
genome (Table 2) were compensatory, they were not
sufficient to restore replication competence to the level of
wt virus.
The peak titer for wt WNV in C6/36 cells was about
8.75×108 pfu/ml, achieved on day 6 post-infection (Fig. 5A).
WNV/DV5′TR99nt and WNV/DV3′USL viruses attained
slightly lower peak titers of 1.25×108 and 2.25×107 pfu/ml,
respectively. The replication of WNV/DV5′TR387nt virus was
retarded at early times post-infection, but the kinetics paralleled
those of wt virus between days 3 and 5. However, the peak titer
only reached 4.25×106 pfu/ml at day 7, almost 200-fold lower
than that of the wt virus. Results in C6/36 cells roughly pa-
ralleled those seen in Vero cells, and differences among the
growth curves in general paralleled the differences in the re-
spective specific infectivities of the RNAs, as demonstrated in
the infectious center assay.
Viruses recovered from infectious supernatants were used for a
determination of plaque size on day 5 post-infection of confluent
monolayers of Vero cells. The plaque size of WNV/DV5′TR99nt
andWNV/DV3′USL viruses (construct D in Fig. 2) ranged from 2
to 3.5 mm in diameter, smaller than that of wild type virus (about 4
to 6 mm). In contrast, WNV/DV5′TR387nt virus produced minute
plaques at day 5 post-infection (data not shown), and plaques were
still smaller than 1.5mm diameter at day 8 post-infection (Fig. 5B).
These results, taken together, suggested that both the DV2 5′NCR
and the DV2 3′NCR upstream from the 3′SLwere quite functional
in the context of WNV replication. However, substitution of the
WNV capsid protein gene by the corresponding DV2 gene, in the
context of the relevant chimeric genomes, reduced the efficiency of
WNV replication by all measurements.
Fig. 5. (A) Growth of viable WN/D2 chimeric viruses in Vero and C6/36 cells. Plaque titers were determined for pools of viruses derived from transfected Vero cells.
These viruses were used to infect confluent monolayers of Vero and C6/36 cells at a multiplicity of infection of 0.01. Viruses in the supernatant of infected cell
monolayers were plaque titered on Vero cells on the days shown post-infection. Wt WNV, open triangles; WN/DV5′TR99nt virus, closed circles; WN/DV3′USL virus,
open diamonds; WN/DN5′TR387nt virus, data points indicated by “×”. (B) Plaque size differences among chimeric mutant viruses as compared to wt WNV. Vero cells
were infected with stock viruses as described under Materials and methods, and plaques were stained with crystal violet at day 5 post-infection, except for plaques
formed by WNV/DV5′TR387nt virus, which were stained at day 8 post-infection.
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MFold
The nt sequences of the 5′NCRs and 5′ORFs in the DV2 and
WNV genomes are divergent, as noted above. The 3′NCRs of
the respective genomes are also highly divergent except for the
CS1 nt sequence already mentioned and CS2, a 23-nt sequence
that is strongly conserved between the WNVand DV2 genomes(reviewed in Markoff, 2003). In order to assess the effects of the
substitution of WNV sequences with corresponding regions of
the DV2 genome on 5′/3′ base pairing, we used both the
MFOLD algorithm (v3.2) for RNA secondary structure analysis
(Zuker et al., 1991) and the program RNAdraw (Matzura and
Wennborg, 1996). Results were the same for either method of
predicting secondary structure. To avoid potential generation of
alternate secondary structures arising from different lengths of
Fig. 6. Predicted RNA secondary structures resulting from 5′ and 3′ end interactions. The potential 5′ and 3′ end interactions were predicted using both RNAdraw (Matzura andWennborg, 1996) andMFOLD v3.2 (Zuker
et al., 1991) algorithms. (A) Wt DV2 RNA; (B) WNV RNA; (C) WN/DV3′USL RNA; (D) WN/DV5′99nt RNA; (E) WN/DV5′TR387nt RNA. WN/DV5′99nt RNA contained an AAT to CAA mutation of nts 100–102,
which was introduced in association with generating the chimera. The 5′/3′ CS base pair interactions are indicated by ovals. Additional hydrogen bonding due to an interaction of the 5′ and 3′ UAR nt sequences (in the












179L. Yu et al. / Virology 374 (2008) 170–185RNA and complications in interpretation of data, we analyzed
equal lengths of wild type and chimeric RNAs. All minigenome
RNAs entered into this analysis contained a total of 438 nts, 195
nts derived from the respective 5′TRs plus 243 nts derived from
the respective 3′NCRs.
The results predict that a 5′/3′ terminal association occurs
in viable mutant RNAs, resulting in secondary structures at
least loosely comparable to those predicted for the respective
wt RNAs (Fig. 6). Comparison of wt DV2 and WNV
minigenome RNA secondary structures (Figs. 6A and B,
respectively) with those of mutant RNAs with heterologous
5′- or 3′-end sequences, for example, WNV/DV3′USL
(Fig. 6C), WNV/DV5′TR99nt RNA (Fig. 6D) and WNV/
DV5′TR387nt RNA (Fig. 6E), revealed that base pairing
between the 5′CS and the “cyc” nt sequence was predicted to
occur in all cases. In addition, wt DV2, wt WNV and WNV/
DV3′USL RNAs (Fig. 6) formed a 12- to 15-bp duplex
between 5′ and 3′ nt sequences previously defined as
“Upstream AUG Regions” (UARs) (Alvarez et al., 2005a).
UAR base pairing was also predicted to be retained in mutant
RNAs WNV/DV5′TR159nt3′NCR, WN/DV5′TR159nt3′SL
and WNV/DV5′99nt/DV3′SL (data not shown), yet none of
these latter mutant RNAs were viable (Figs. 3A and 4B),
possibly owing to the chimerization of the capsid gene or to
the dominant influence of the 3′SL nt sequence in determin-
ing viability. In contrast, there were no UAR base pairings
predicted in some viable mutant RNAs, including WNV/
DV5′TR99nt (Fig. 6D) and WNV/DV5′TR387nt RNAs (Fig.
6E). This was a possible indication that the UAR base
pairings are dispensable for replication in the presence of the
homologous 3′SL nt sequence. The predicted secondary
structure of WN/DV5′TR387nt minigenome was aberrant in
several other ways compared to those of all other viable
RNAs, all of which replicated with much greater efficiency.
Perhaps this was a factor in the relative lack of infectivity of
this construct.
Discussion
Weused a previously established in vitro assay for polymerase
activity of purified WNV and DV2 NS5 proteins (Ackermann
and Padmanabhan, 2001; Nomaguchi et al., 2004; You et al.,
2001; You and Padmanabhan, 1999) to determine their ability to
catalyze synthesis of de novo RNAs off the 3′ terminus of DV2,
WNVand chimeric RNAs containing nt sequences derived from
the 5′TRs and the 3′NCRs of the two genomes. To correlate the in
vitro results with virus physiology, we then determined the
infectivity of genome-length WNV RNAs containing strategic
substitutions of DV2 nt sequences for WNV nt sequences
comprising the 5′TR and/or the 3′NCR. We had previously
shown in two separate studies that 3′SL nt sequences en bloc
could not be swapped in either direction between the DV2 and
WNV genomes without abrogating infectivity of the parent
genome (Yu and Markoff, 2005; Zeng et al., 1998). A goal of
the present work was to determine whether further substitution
of 5′TR and 3′NCRWNV nt segments known to be required for
RNA replication by analogous DV2 nt segments, in the contextof the nonviable WNV genome in which the WNV 3′SL was
substituted by DV2 3′SL nt sequences (WN/DV3′SL RNA;
Fig. 2), could restore replication competence. The effects of
these additional substitution mutations on WNV replication
were also assessed by introducing them into a fully wt WNV
genome.
As for other RNAviruses (Blumenthal and Carmichael, 1979;
Herold and Andino, 2001; Hewlett et al., 1977; Hsu et al., 1973;
Hu et al., 2007; Ooms et al., 2007), circularization of the genome
appears to be a prerequisite for replication of flavivirus RNAs
(Alvarez et al., 2005b; Filomatori et al., 2006). The conserved 5′
and 3′ cyclization motifs in flavivirus genomes were initially
shown to be required for negative strand RNA synthesis by in
vitro methods (Ackermann and Padmanabhan, 2001; Nomagu-
chi et al., 2004; You et al., 2001; You and Padmanabhan, 1999).
A physical interaction between 5′ and 3′ terminal nt sequences
dependent on complementarity between the two cyclization
motifs was demonstrated by psoralen–UV cross-linking (You
et al., 2001) and recently by atomic force microscopy (Alvarez
et al., 2005b). The requirement for complementarity of the
cyclization motifs in RNA replication was also established using
flaviviral replicon RNAs (Alvarez et al., 2005a; Corver et al.,
2003; Khromykh et al., 2001; Lo et al., 2003) and mutant
genomes derived from infectious DNAs (Alvarez et al., 2005b;
Bredenbeek et al., 2003).
Given the conservation of the 5′CS and its 8-nt complement
within CS1 in the WNV and DV2 genomes, we assumed that
differences we observed in activity of the relevant mutant RNAs
in vitro and replication efficiency of analogous mutant genomes
in vivo were determined by nt sequence differences between the
two genomes that occur upstream and downstream from the
formally recognized cyclization segments, either by an effect on
5′/3′ hydrogen bonding or by the possible effects of nt substi-
tutions on binding of viral or cellular proteins necessary for
replication. For example, the 5′CS is part of a larger conserved nt
sequence element that was originally predicted to participate in
5′/3′ hydrogen bonding with the entirety of CS1 in the 3′NCR
(Hahn et al., 1987). In support of that hypothesis, Corver et al.
(2003) demonstrated that nts 147 through 165 (within the capsid
gene ORF) were required for fully efficient replication of a
replicon derived from the Yellow Fever strain 17D (YF)
genome. Since the 5′ terminus of the 8-nt 5′CS maps to nt 156
in the YF genome (Khromykh et al., 2001), the domain mapped
by Corver et al. (2003) closely corresponds to the one originally
described by Hahn et al. (1987) in that it included the 5′CS plus
an additional 9 nts upstream and 2 nts downstream and is com-
plementary to CS1 in the YF genome. CS1 within the WNVand
DV2 genomes are slightly divergent from each other; they differ
in nt sequence at 2 positions, and in addition CS1 of the DV2
genome is one nt shorter than that of the WNV genome (re-
viewed in Markoff, 2003). These small differences in nt
sequence may in fact account for some of our observations of
specificity in the in vitro system (see below).
Hydrogen bonding between the 5′ and 3′UARs was deemed
to be an additional important factor for RNA circularization and
replication competence (Alvarez et al., 2005a). However, the 5′
and 3′ UAR nt sequences are also conserved between the WNV
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serve efficiently as template for in vitro RNA synthesis or of
chimeric genome RNAs to replicate in transfected cells was
unlikely per se to be due to a lack of complementarity between
5′ and 3′ UARs, although alteration of the nt sequences up-
stream or downstream from the UARs might conceivably inter-
fere with their hydrogen bonding. In fact, using MFold, the 5′
and 3′UARs in two viable mutant RNAs, WNV/DV5′TR99nt
and WNV/DV5′TR387nt, were not predicted to base pair. Since
the analysis was based on limited sequence data and is further
limited by the predictive accuracy of MFold per se, we would
hesitate to draw any firm conclusions from this finding. How-
ever, it should be noted that the 3′UAR is composed of nts that
alternatively base pair with each other to form the bottom part of
the long stem in the 3′SL (Alvarez et al., 2005b). Thus the
consequence of hydrogen bonding between the UARs is a
foreshortening of the length of the long stem in the 3′SL.
Results of the MFold analysis are indicative that the “classical”
3′SL structure (Brinton et al., 1986; Hahn et al., 1987; Rice
et al., 1985; Wengler and Castle, 1986) is thermodynamically
favored over hydrogen bonding between the UARs in the con-
text of the two mutant RNAs used for the MFold analysis.
According to the proposed model (Filomatori et al., 2006),
NS5 polymerase initially recognizes and binds the SLA. Circu-
larization of the genome (and possibly the action of other proteins)
presumably brings the 3′ terminus into a close spatial relationship
with SLA, permitting the replicase to commence negative strand
RNA synthesis. The SLA nt sequence is also conserved between
the WNV and DV2 5′NCR nt sequences, despite their roughly
50% overall nt sequence similarity. Conservation of the SLA nt
sequence and of the 5′UAR nt sequence may account in part for
our finding that the 5′NCR of the DV2 genome can substitute for
the 5′NCR of the WNV genome in the context of the WNVRNA
with no significant loss of viability.
Some known characteristics of the requirement for the 3′SL in
negative strand RNA synthesis were briefly discussed in the
Introduction section. In contrast to the formal cyclization
sequences, the 5′ and 3′UARs, and SLA, the nt sequences of the
WNVandDV23′SLs are highly divergent, and the loci of bulges in
the long stems of these structures that are required for RNA
replication are different for the two different 3′SLs. This appeared
to account for the finding that theWNVandDV2 3′SLs en bloc are
not interchangeable between the two genome RNAs (Yu and
Markoff, 2005; Zeng et al., 1998). Finally, the 3′NCRs of the DV2
and WNV genomes differ significantly in total length (451 nts vs.
631 nts, respectively). Both contain additional mosquito-borne
flavivirus-conserved features (such as CS1, CS2 and RCS2;
reviewed in Markoff, 2003) upstream from the 3′SL, and there are
data to implicate some of the conserved stem–loop structures
upstream from the 3′SL as functionally important inRNAsynthesis
(for example see Men et al., 1996). However, the WN genome
contains a pair of tandem repeat nt sequences (CS3 and RCS3) not
found in the DV2 3′NCR. Our results suggest that CS3 and RCS3
are not needed for WNV replication in Vero or C6/36 cells.
In the in vitro system, the DV5′TR230nt RNAwas not able to
stimulate highly efficient synthesis of 3′-elongation product
RNAoff theWNV3′NCR, catalyzed by theWNVNS5, whetherthe 5′TR was provided in trans or in cis. Conversely, both the
WNV and the DV2 NS5 were relatively inactive when
presented with constructs in which the 5′TR and 3′NCR
were heterologous (in D21–208WN3′NCR and WN1–161D23′NCR
minigenome RNAs). These in vitro results paralleled those
observed after transfection of aWNVmutant RNA that contained
a DV2-derived 5′TR, including the entirety of the DV2 capsid
gene ORF (WN/DV5′TR387nt RNA). The mutation was not
ultimately lethal, but evidence of virus replication by IFAwas not
obtained until day 20 post-transfection, and the RNA had a
significantly lower specific infectivity compared to wt and other
viable mutant RNAs. Data indicated that inefficient replication of
theWN/DV5′TR387nt mutant virus was due to a defect at the level
of RNA synthesis possibly resulting from relative lack of com-
plementarity between nts in the DV2 capsid gene segment with nt
sequences in the WNV 3′NCR. This was consistent with the
previously cited work with the YF replicon (Corver et al., 2003)
where replication efficiency was sensitive to even a 2-nt deletion
of the YF capsid gene nt sequence complementary to CS1 and
was completely abrogated by a 3-nt substitution mutation that
reduced 5′/3′ complementarity within this segment.
One major difference between the DV2 and WNV NS5 RdRP
activities in the in vitro systemwas seenwithWN1–95D296–230+3′NCR
minigenome RNA as template. The DV2 polymerase was
consistently more active with this template than was the WNV
polymerase. It is tempting to ascribe this difference in activity to the
species specificity of the 3′SL that was demonstrated in the
previous (Yu and Markoff, 2005; Zeng et al., 1998) and present in
vivo studies. However, this specificity was not otherwise observed
in vitro; the WNV polymerase did not discriminate between
minigenomes containing all-DV2 and all-WNV 5′ and 3′NCR nt
sequences, and theDV2polymerase exhibited significant (although
reduced compared to control) activity in the presence of the
WNV818nt template. Therefore, we speculate that the superior
activity of the DV2 NS5 compared to the WNV NS5 with the
WN1–95D296–230+3′NCR template could have been due in part to an
interaction between the homologous DV2 5′ORF nts included in
the construct (i.e., nts 96–230) and theDV23′NCR that favored the
DV2 polymerase. In light of these results, the observed phenotypes
of the D21–208WN3′NCR andWN1–161D23′NCR minigenome RNAs
in vitro and of WN/DV5′TR387nt RNA in vivo, and the cited work
with theYF replicon (Corver et al., 2003), it appears that replication
efficiency is extremely sensitive to nt sequences, especially those
within the capsid gene ORF, that may lie upstream or downstream
from the commonly described conserved segments needed for
genome circularization.
Other newdata presented here show that no segment of the 5′TR
or 3′NCRupstream from the 3′SL can “rescue” a nonviable mutant
WN genome bearing the DV2 3′SL; all mutant genome RNAs in
which the 3′SL was heterologous to the non-structural proteins
were unable to replicate. Conversely, no other DV2 nt segment
within the 5′TR and 3′NCR was per se lethal to replication of
substitution mutant WNV RNAs. (Specifically, the DV2 5′NCR,
capsid ORF and the 3′NCR upstream from the 3′SL were
individually tested in the context of substitution mutant WNV
genomes, and all RNAs yielded viable viruses.) These observations
favor the hypothesis that viral NS proteins other than NS5 (rather
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specificity of the 3′SL. Taken together with our previous work
demonstrating that the loci of bulges in the long stem of the DV2
andWNV 3′SLs are determinants of their specific requirements for
negative strand RNA synthesis (Yu andMarkoff, 2005; Zeng et al.,
1998), we would now therefore posit that binding of viral NS
proteins other than NS5 to such bulges in the long stem mediates
this specificity. Cellular proteins also play an as yet undefined role
in these processes, possibly a la the role of PABP in the
circularization of poliovirus RNA (Herold and Andino, 2001).
One cellular protein likely to be involved in WNV replication is
eEF1A (Davis et al., 2007).
Materials and methods
Construction of homologous and chimeric minigenome DNA
templates
The construction of DNA plasmids encoding the D2719nt
and WN1051nt minigenome RNAs (pSY-2719nt and pSP64-
WNV1051nt DNAs, respectively) has been described elsewhere
(Nomaguchi et al., 2004; You and Padmanabhan, 1999; You
et al., 2001). In summary, pSY-2719nt DNA contained the 227-nt
5′ terminus of the dengue-2 virus (DV2) strain NGC genome in
covalent linkage to a 3′ terminal fragment of the genome
containing the last 41 nts of the NS5 ORF (including the stop
codon) plus the entire 451-nt 3′NCR. pSP64-WNV1051nt DNA
contained the 5′ terminal 281 nts of the West Nile virus (WNV)
strain Eg101 genome fused to the 3′ terminal 770 nts, i.e., the last
139 nts of the NS5 ORF plus the 631-nt 3′NCR. To construct the
pSP64-WNV818nt plasmid DNA encoding WN818nt RNA, the
pSP64-WNV1051nt plasmid (3 μg) was sequentially incubated in
50 μl reaction volume with BsmI, which cut the DNA at nt 161
within the 5′ terminal nt sequences, and BbsI, which cut the
DNA at nt 385 of the construct, 666 nts upstream from the 3′
terminus of the genome, for 3 h at 37 °C and 3 h at 65 °C. The
DNAwas purified by QIAquick purification kit (Qiagen), blunt-
ended with Klenow DNA polymerase (5 U/50 μl volume) and
incubated with T4 DNA ligase. The ligation product was cloned
using standard protocols. This procedure removed nucleotides
between BsmI and BbsI sites to yield the pSP64-WNV818nt
plasmid.
The recombinant plasmid template for D21–208WN3′NCR
RNA was created by digestion of pSP64-WNV1051nt and DV2
pSY-2 plasmids (3 μg each) with EcoRI (24 U) (which cut at a
single site in the vector upstream from the T7 promoter) for 2 h at
37 °C followed by digestion with BsmI (20U) (which cut the
WNV DNA at 161 and the DV2 DNA at nt 208, within the
respective 5′ terminal nt sequences in these fragments) at 65 °C
for 2 h. The plasmids were purified on a QIAquick column after
each digestion. The larger product of SP64-WNV1051n plasmid
DNA digestion was treated with calf intestinal alkaline
phosphatase (CIAP) at 37 °C for 1 h, purified by agarose gel
electrophoresis and extracted using a QIAquick gel extraction
kit. The DV2-specific insert released from the pSY-2 plasmid by
EcoRI and BsmI digestion was cloned between the EcoRI and
BsmI sites of the pSP64-WNV1051nt plasmid. The productmolecule was then sequentially digested to remove redundant
WNV nts between the BsmI site and the BbsI site, blunt-ended
with Klenow fragment, religated with T4DNA ligase and cloned
to yield D21–208WN3′NCR DNA. The WN1–161D23′NCR plasmid
DNA was constructed in an analogous manner, by digesting
pSP64-WNV1051nt DNA and the DV2 pSY-2 plasmid with
EcoRI and BsmI. The resulting recombinant vector DNA frag-
ments containing the 5′ terminal 161 nts of the WNV genome
and the 3′NCR of the DV2 genome, respectively, were gel
purified, ligated and cloned to yield the desired construct. To
construct the WN1–95D296–230+3′NCR DNA, the recombinant
plasmids SP64-WNV818nt and DV2 pSY-2 were doubly digested
with the restriction endonucleases EcoRI and BglII, releasing
fragments bearing nts 1–95 of the WNV and DV2 genomes,
respectively. The WNV-specific fragment was then cloned into
DV2 pSY-2 plasmid DNA from which the DV2-specific
EcoRI–BglII fragment had been removed. All constructs were
verified by nt sequence analysis.
Generation of full-length WNV-DV2 chimeric cDNAs
A recombinant plasmid DNA containing a full-length copy of
the WNV strain 956 genome, pSP6WN/Xba (strain 956,
GenBank M12294), was reported previously (Yamshchikov
et al., 2001). The full-lengthWNVDNA insert was initially sub-
cloned into a pRS424 yeast shuttle vector (http://seq.yeastgen-
ome.org/vectordb/vector_descrip/PRS424.html) at ClaI and
NotI sites, resulting in recombinant pRSWN DNA. To construct
either 5′- or 3′-terminal WNV/DV2 chimeric mutants, the 5′
terminal ∼2 kb of the WNV DNA was released from pRSWN
DNA by digestion with restriction endonucleasesKpnI (pRS424
1894) and SacI (WNV nt 2199) and inserted into the pBluscript
vector (Stratagene, La Jolla, CA) at SacI–KpnI sites to yield
pBWN2K. Then a∼4 kb fragment of the DNA containing the 3′
terminus of the WNV genome was released from the pSP6WN/
Xba plasmid by digestion with SphI (WNV nt 6777) and XbaI
(WNV nt 10,962) and cloned into the pGEM vector (Promega,
Madison, WI) at the same sites to yield pGWN4K.
The pGWN4KDNAwas used tomake substitution mutations
in the WNV 3′NCR. To create pGWN4K/DV 3′UCS (a sub-
stitution of WNV 3′NCR nt sequences upstream from CS1 by
analogous DV2 nt sequences), a pair of primers were used to
synthesize a PCR copy of the DV2 “3′UCS” nt sequence. ADV2
10,282 BglII sense primer, AACTAGATCTAACATGAAA-
CAAGGCTAGAAGTCAGG, containing the DV2 nts 10,282 to
10,309 and a 5′ terminal BglII recognition sequence (under-
lined), and a DV2 10,601 AgeI antisense primer, AAA-
TACCGGTCTCCTCTAACCTCTAGTCCTTCCAG, containing
DV2 nts 10,601–10,574 and a 5′ terminal AgeI site (underlined).
Wild type DV2 DNA (Polo et al., 1997) was used as a template.
The entire pGWN4K DNA sequence was also PCR-amplified
using a sense primer with a 5′ terminal AgeI site, AAATACC-
GGTGCCAAAAACACCAAAAGAAACAGCATATT (WNV
nt 10,833–10,863) and an antisense primer with a 5′ terminal
BglII site, AATTAGATCTCATTCTCAATAAATCCTATTTA-
CACTAA (WNV nt 10,437–10,410). The DV2 3′UCS and the
linear pGWN4K PCR products were treated with BglII and
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to produce pGWN4K/DV.3′UCS DNA.
To create pGWN4K/DV.3′NCR DNA, a DNA fragment
containing the DV2 3′NCR was PCR-synthesized using the
DV2.10282 BglII sense primer (see above) and an antisense
primer (DV2.3′Xba) containing a 5′ terminal XbaI site and nts
complementary to DV2 nts 10,723–10,696 (CATATCTAGA-
GAACCTGTTGATTCAACAGCACCATTC). The PCR frag-
ments were digested with BglII and XbaI and ligated to
pGWN4K/DV.3′UCS DNA that had been linearized with the
same restriction endonucleases in a fragment swap, resulting in
pGWN4K/DV.3′NCR DNA.
To create pGWN4K/DV.3′USLDNA, the plasmid pGWN4K/
DV.3′UCS was PCR-amplified with a pair of primers (a sense
primer CCTGGGATAGACTAGGGGATCTTCTGC, WNV nt
10,868–10,894) and a 5′ phosphorylated antisense primer con-
taining the complement of the DV2 3′CS nt sequence, CGTC-
AATATGCTGTTTTTTGTTTTGGGGGGGTCTCCTCTA-
ACCTCTAGTCCTTCCAGTG, DV2 nt 10,631–10,573). The
PCR products were self-ligated at blunt ends and used to
transformE. coli to produce pGWN4K/DV.3′USL.Next, all three
mutant recombinant plasmid DNAs, pGWN4K/DV.3′UCS,
pGWN4K/DV.3′USL and pGWN4K/DV.3′NCR, were digested
with SphI (which cuts WNV DNA at nt 6774) and XbaI (which
cuts WNV DNA at nt 10,962). The SphI–XbaI fragments con-
taining 3′NCR substitution mutations were then inserted into
pSP6WN/Xba DNA that had been linearized with SphI and XbaI
to produce WN/DV3′UCS, WN/DV3′USL and WN/DV3′NCR
cDNAs, respectively.
Next, we created the WNV/DV2 chimera in which the DV2
5′NCR replaced the corresponding region in the WNV genome,
except for a Ser to Gln mutation at the second amino acid (aa) in
the ORF, as follows. DV2 5′ NCR fragment (nt 1–99) was
obtained by PCR using the DV2 strain NGC infectious DNA
(Polo et al., 1997) as the template, a forward primer containing a
ClaI restriction site upstream of SP6 promoter sequences,
TAACATCGATTAGAATTTAGGTGACACTATAG, and a 5′
phosphorylated reverse primer containing DV2 nts 99–73, CATC-
AGAGATCTGCUCTCTAATTAAAAAAC. The pBWN2K plas-
mid DNA was also PCR-amplified with a pair of primers (an
antisense Cla primer, GCTTATCGATACCGTCGACCTC-
GAGGGGGG, complementary to pRS424 nts 1939–1914, and
a sense primer containing WNV nts 103–130 with the second
code mutation, CAAAAGAAACCAGGAGGGCCCGGT-
AAAACC). Both the DV2 5′NCR and the pBWN2K plasmid
DNA PCR products were treated with ClaI, ligated and
transformed into E. coli to produce the chimeric recombinant
DNA plasmid, pBWN2K/DN5′TR99nt. Then the pBWN2K/
DN5′TR99nt DNA was digested with ClaI and MluI (WNV nt
918), and the excised WNV DNA fragment of about 1 kb,
containing the DV2 5′NCR, was inserted into pSP6WNV/XbaI
andWNV/DV3′SL DNAs (Yu andMarkoff, 2005) that had been
linearized by digestion at the same unique ClaI and MluI sites,
resulting in WNV/DV5′TR99nt and WNV/DV5′TR99nt3′SL
DNAs, respectively (Fig. 3B, top and bottom).
A similar cloning strategy was used to construct WNV/DV5′
TR159nt and WNV/DN5′TR387nt chimeric cDNAs. For WNV/DV5′TR159nt,which contained theDV25′NCRplus theN-terminal
first 21 codons of the DV2 ORF substituted for the analogous
WNV nt sequences in the context of the WNV DNA backbone,
DV2 5′TR159nt fragment was PCR-synthesized with DV2 DNA as
template and with a pair of primers (a sense Cla primer as shown
above, and a 5′phosphorylated antisense primer complementary to
DV2 nts 159–133, GTTTCTCTCGCGTTTCAGCATATT-
GAAG). The pBWN2K vector was PCR-amplified to produce a
linear product molecule from which WNV nts 1–159 had been
deleted, using an antisense Cla primer and a sense primer com-
plementary to WNV nt160–184, CCCCGCGGATTGTCCTT-
GATAGGAC). Both PCR products were digested with ClaI,
ligated and transformed into E. coli cells to produce pBWN2K/
DN5′TR159nt. The 5′-chimeric fragment was then cleaved from
pBWN2K/DN5′TR159nt recombinant plasmid DNAwith ClaI and
MluI and inserted into pSP6WN/Xba DNA, after that DNA was
also doubly digested to produce WNV/DV5′TR159nt DNA. To
construct chimeric WN/DV5′TR159nt DNAs containing substitu-
tionmutations of theWNV3′NCRby theDV2 3′NCRor ofWNV
3′NCR nt sequences upstream from the 3′SL by analogous DV2 nt
sequences (3′USL), 5′-end 1 kbp fragments were cleaved from the
pBWN2K/DN5′TR159nt DNA with ClaI and MluI and were
inserted into WN/DV3′NCR and WNV/DV3′USL (described
above) at the same sites to produceWNV/DV5′TR159nt3′NCR and
WNV/DV5′TR159nt3′USL cDNAs, respectively.
To construct theWN/DV5′TR387nt DNA, the DV2 5′-TR387nt
fragment was PCR-amplified using DV2DNA as template and a
pair of primers (a sense Cla primer as shown above, and a 5′
phosphorylated antisense primer complementary to DV2 nts
387–361 (CCTGTTCAAGATGTTCAGCATCCTTCC). The
pBWN2K vector was also PCR-amplified to produce a linear
product that lacked nts 1–387 of the WNV genome, using a pair
of primers (an antisense Cla primer and a sense primer
containing WNV nts 388–416, CGGAGCACAAAACAAAA-
GAAAAGAGGAGG). Both PCR products were digested with
ClaI, ligated and used for transformation of E. coli to produce
pBWN2K/DV5′TR387nt. The chimeric fragment containing
DV2 capsid gene nt sequences was then cleaved from
pBWN2K/DV5′TR387nt with ClaI and MluI and inserted into
pSP6WN/Xba, WN/DV3′SL and WN/DV3′NCR DNAs at the
same sites to obtain WN/DV5′TR387nt 3′SL DNA and WN/
DV5′TR387nt 3′NCR DNA, respectively.
All cloned plasmidswere analyzed by restriction endonuclease
digests (New England BioLabs, Beverly, MA) and by partial
sequencing using Big Dye Terminator kit and an ABI model 377
DNA sequencer (Applied Biosystems, Foster City, CA). All
plasmids were purified with Miniprep kit (QIAGEN, Valencia,
CA) and then used for synthesis of their RNA counterparts.
Preparation of RNAs containing 5′TR and the WNV 3′NCR nt
sequences
RNAs containing sequences from the 5′ and 3′TRs of the DV2
and WNV genomes, as well as the DV2/WNV chimeric RNAs,
were synthesized in vitro from the corresponding PCR amplified
DNA fragments. The DNAs were obtained as follows. The PCR
fragment encoding DV2 nts 1–230 was obtained as described
183L. Yu et al. / Virology 374 (2008) 170–185previously (You and Padmanabhan, 1999). The PCR fragment
containing WNV nts 1–230 downstream from the T7 promoter
was also obtained as described previously (Nomaguchi et al.,
2004), with a WNV DNA template. The PCR fragment
containing the chimeric 5′TR RNA, WN5′NCR-DV5′ORF
(WN nts 1–95 fused to DV2 nts 96–230), was obtained using
WN1–95D296–230+3′NCR DNA as template (see above). The EcoRI
primer described above was used as forward primer, and the
reverse primer was complementary to DV2 nts 233–217. The
PCR fragment encoding the 5′TR RNA, DV5′NCR-WN5′ORF
(DV2 nts 1–95 fused to WNV nts 96–230), was obtained
in the converse manner using a minigenome DNA containing
D21–95WN96–230+3′NCR nt sequences (created using the respective
wt template DNAs and techniques based on the conserved BglII
recognition sequence in both genomes, as described above for
derivation of WN1–95D296–230+3′NCR DNA) and a reverse primer
complementary to WN nts 230–207. Derivation of the RNA
containing the 631-nt sequence of theWNV strain Eg101 genome
was previously described (Nomaguchi et al., 2004).
All PCR reactions were performed with Vent polymerase
(New England Biolabs). PCR products were purified using the
QIAquick gel extraction kit (Qiagen) prior to use in the in vitro
transcription reaction, as described previously (Nomaguchi et al.,
2004). To generate RNAs used in transactivation assays, the PCR
products derived as per above, containing T7 RNA polymerase
promoters, were used for in vitro transcription. Transcripts were
purified as previously described (You and Padmanabhan, 1999)
and used in the in vitro RdRP assays (see below).
In vitro RdRP assays using purified WNV and DV2NS5
DV2 and WNV NS5 were expressed in E. coli and purified as
described previously (Ackermann and Padmanabhan, 2001;
Nomaguchi et al., 2004). Purified NS5 was stored in a buffer
containing 40% glycerol at 20 °C prior to its use in RdRP assays.
RNA templates were prepared by in vitro transcription on
linearized DNA templates containing the region to be transcribed.
In vitro transcription was carried out using the Ampliscribe T7
Transcription kit (Epicentre Technologies). The standard reaction
mixture (50 μl) contained 50 mM Tris–HCl (pH 8.0), 50 mM
NaCl, 5 mM MgCl2, 0.1 mM dithiothritol, template RNA
(0.3 μg), 500 μM (each) ATP, GTP and UTP, 10 μM unlabeled
CTP and 10 μCi of [α-32P]CTP along with 270 ng (2.6 pmol) of
purified NS5. The reaction was incubated for 60 min at 30 °C.
For trans-activation assays, the 5′TR RNA was labeled with
[32P] in an in vitro transcription reaction. The reaction was
terminated by extraction with acid chloroform/phenol followed
by ethanol precipitation in the presence of 50 μg of E. coli
tRNA as a carrier. The unincorporated nucleoside triphosphates
were removed by using a Biorad P30 column. The in vitro
RdRP products were analyzed by formaldehyde-agarose (2%)
gel electrophoresis and autoradiography.
RNA transfection and indirect immunofluorescence assays (IFAs)
Plasmid DNA (1 μg) linearized by digestion with the XbaI
was used as the template for RNA transcription catalyzed bySP6 RNA polymerase (Promega, Madison, WI), as previously
described (Polo et al., 1997; Yu and Markoff, 2005; Zeng et al.,
1998). Wt and mutant WNV RNAs derived by in vitro
transcription were transfected into Vero cells to determine the
replication phenotypes of mutant WNV viruses. IFA was per-
formed to examine expression of viral protein during replication.
Detailed procedures for RNA transfection of Vero cells and IFA
were previously described (Polo et al., 1997; Yu and Markoff,
2005; Zeng et al., 1998).
Infectious center assay, plaque assay and virus growth curve
Approximately 106 Vero cells in a volume of 300 μl of PBS
were transfected by electroporation as previously described
(Yu and Markoff, 2005), using 0.5 μg of RNA derived by
transcription of cloned Wt or mutant recombinant plasmid
DNAs. Briefly, serial 10-fold dilutions of transfected Vero
cells were performed with MEM containing 2×105 fresh Vero
cells and were seeded onto paired wells of six-well tissue
culture plates. Plates were incubated for 4 h at 37 °C in 1×
MEM. The media were removed and the cell monolayers were
overlaid with 1% agarose (BioWhittaker, Rockville, MD)
containing 1× Earle's balanced salts (Sigma, Saint Louis,
MO), 1 mM sodium pyruvate (Gibco-Invitrogen, Carlsbad,
CA), 1× NEAA (BioWhittaker, Rockville, MD), 1× vitamins
(Gibco-Invitrogen, CA) and 10% fetal calf serum (Atlanta
Biologicals, Lawrenceville, GA). Plates were incubated for
5–8 days at 37 °C under 5% CO2. Cells were then fixed
with 7% formaldehyde for 1 h at room temperature. The
agarose layer was then removed, and cell monolayers were
stained with 1% crystal violet to visualize plaques which
were counted. The RNA specific infectivity was expressed as
the number of pfu (plaque-forming units) per microgram of
RNA.
For titration of virus infectivity by plaque assays, each of the
supernatants derived from transfected or infected Vero cells was
harvested when about 100% of the cells were positive for viral
antigens. Monolayers of Vero cells were infected with 10-fold
serial dilutions of stock viruses at 37 °C for 1–2 h in 1× MEM.
The monolayers were overlaid with agarose and after 5–8 days
of incubation at 37 °C under 5% CO2 were stained with 1%
crystal violet as described above.
To determine virus growth kinetics, Wt WNV virus and each
of the viable mutant viruses released from Vero cells were used
to infect both Vero cells in six-well plates and C6/36 cells in
T-25 flasks at a multiplicity of infection (MOI) of 0.01. Then,
300 μl of supernatant from infected cells was harvested daily for
virus titration. The volume of supernatant removed each day
was replaced with fresh medium. Virus titers for each cell line
were determined by plaque assay on Vero cells as described
above.
Sequencing of RNAs isolated from viable mutant viruses
Details of the sequencing of mutant virus RNA prepared
from recovered progeny viruses were previously described (Yu
and Markoff, 2005).
184 L. Yu et al. / Virology 374 (2008) 170–185Computer analysis of predicted secondary structures of wt and
mutant RNA
A 438-nt segment (195 nt from 5′-end and 243 nt from 3′-
end) of wt or mutant RNAs was analyzed for the predicted
secondary structures for potential 5′–3′ interaction using the
MFOLD algorithm (Zuker et al., 1991) and the program
“RNAdraw”, an integrated program for RNA secondary struc-
ture calculation and analysis on a Microsoft Windows platform
(Matzura and Wennborg, 1996).
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